GAMCO Investors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-61,100
Closed -$2.84M 886
2023
Q2
$2.84M Buy
+61,100
New +$2.11M 0.03% 424

GAMCO Investors's DICE Position: Q3 2023 in Review

GAMCO Investors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 61,100 shares — an estimated $2.84M sold.

GAMCO Investors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $2.84M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • GAMCO Investors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • GAMCO Investors sold 61,100 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.84M.
  • GAMCO Investors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • GAMCO Investors's DICE Therapeutics, Inc. Common Stock position peaked at $2.84M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on GAMCO Investors's 13F filing for Q3 2023, filed 8 Nov 2023.